nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.162	0.198	CbGbCtD
Praziquantel—CYP3A7—Ifosfamide—testicular cancer	0.162	0.198	CbGbCtD
Praziquantel—CYP3A5—Ifosfamide—testicular cancer	0.122	0.148	CbGbCtD
Praziquantel—CYP2C19—Ifosfamide—testicular cancer	0.0982	0.12	CbGbCtD
Praziquantel—CYP3A5—Etoposide—testicular cancer	0.0582	0.0709	CbGbCtD
Praziquantel—CYP3A4—Ifosfamide—testicular cancer	0.0475	0.0578	CbGbCtD
Praziquantel—CYP1A2—Etoposide—testicular cancer	0.0433	0.0528	CbGbCtD
Praziquantel—CYP2D6—Vinblastine—testicular cancer	0.0396	0.0482	CbGbCtD
Praziquantel—CYP3A4—Vinblastine—testicular cancer	0.0252	0.0307	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—testicular cancer	0.0243	0.0296	CbGbCtD
Praziquantel—CYP3A4—Etoposide—testicular cancer	0.0227	0.0276	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—testicular cancer	0.0155	0.0189	CbGbCtD
Praziquantel—Atrioventricular block—Epirubicin—testicular cancer	0.00109	0.00608	CcSEcCtD
Praziquantel—Immune system disorder—Ifosfamide—testicular cancer	0.00108	0.00604	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—testicular cancer	0.00108	0.00604	CcSEcCtD
Praziquantel—Arrhythmia—Ifosfamide—testicular cancer	0.00107	0.00598	CcSEcCtD
Praziquantel—Feeling abnormal—Chlorambucil—testicular cancer	0.00106	0.00592	CcSEcCtD
Praziquantel—Ill-defined disorder—Dactinomycin—testicular cancer	0.00105	0.0059	CcSEcCtD
Praziquantel—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00105	0.00588	CcSEcCtD
Praziquantel—Bradycardia—Cisplatin—testicular cancer	0.00105	0.00587	CcSEcCtD
Praziquantel—Myalgia—Bleomycin—testicular cancer	0.00104	0.0058	CcSEcCtD
Praziquantel—Discomfort—Bleomycin—testicular cancer	0.00103	0.00573	CcSEcCtD
Praziquantel—Malaise—Dactinomycin—testicular cancer	0.00103	0.00573	CcSEcCtD
Praziquantel—Decreased appetite—Vinblastine—testicular cancer	0.00102	0.00572	CcSEcCtD
Praziquantel—Urticaria—Chlorambucil—testicular cancer	0.00102	0.00571	CcSEcCtD
Praziquantel—Abdominal pain—Chlorambucil—testicular cancer	0.00102	0.00568	CcSEcCtD
Praziquantel—Body temperature increased—Chlorambucil—testicular cancer	0.00102	0.00568	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—testicular cancer	0.00101	0.00563	CcSEcCtD
Praziquantel—Feeling abnormal—Vinblastine—testicular cancer	0.000971	0.00543	CcSEcCtD
Praziquantel—Myalgia—Dactinomycin—testicular cancer	0.000968	0.00541	CcSEcCtD
Praziquantel—Ill-defined disorder—Ifosfamide—testicular cancer	0.000966	0.0054	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vinblastine—testicular cancer	0.000963	0.00539	CcSEcCtD
Praziquantel—Cardiac disorder—Cisplatin—testicular cancer	0.000957	0.00535	CcSEcCtD
Praziquantel—Discomfort—Dactinomycin—testicular cancer	0.000956	0.00535	CcSEcCtD
Praziquantel—Anorexia—Bleomycin—testicular cancer	0.000948	0.0053	CcSEcCtD
Praziquantel—Hypersensitivity—Chlorambucil—testicular cancer	0.000947	0.00529	CcSEcCtD
Praziquantel—Malaise—Ifosfamide—testicular cancer	0.000939	0.00525	CcSEcCtD
Praziquantel—Vertigo—Ifosfamide—testicular cancer	0.000936	0.00523	CcSEcCtD
Praziquantel—Immune system disorder—Cisplatin—testicular cancer	0.000932	0.00521	CcSEcCtD
Praziquantel—Abdominal pain—Vinblastine—testicular cancer	0.000931	0.00521	CcSEcCtD
Praziquantel—Asthenia—Chlorambucil—testicular cancer	0.000922	0.00516	CcSEcCtD
Praziquantel—Arrhythmia—Cisplatin—testicular cancer	0.000922	0.00515	CcSEcCtD
Praziquantel—Pruritus—Chlorambucil—testicular cancer	0.000909	0.00508	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000906	0.00507	CcSEcCtD
Praziquantel—Convulsion—Ifosfamide—testicular cancer	0.000903	0.00505	CcSEcCtD
Praziquantel—Myalgia—Ifosfamide—testicular cancer	0.000887	0.00496	CcSEcCtD
Praziquantel—Anorexia—Dactinomycin—testicular cancer	0.000884	0.00494	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000881	0.00492	CcSEcCtD
Praziquantel—Diarrhoea—Chlorambucil—testicular cancer	0.000879	0.00492	CcSEcCtD
Praziquantel—Cardiac disorder—Etoposide—testicular cancer	0.000877	0.0049	CcSEcCtD
Praziquantel—Discomfort—Ifosfamide—testicular cancer	0.000876	0.0049	CcSEcCtD
Praziquantel—Hypersensitivity—Vinblastine—testicular cancer	0.000868	0.00485	CcSEcCtD
Praziquantel—Decreased appetite—Bleomycin—testicular cancer	0.000865	0.00484	CcSEcCtD
Praziquantel—Immune system disorder—Etoposide—testicular cancer	0.000854	0.00477	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000845	0.00473	CcSEcCtD
Praziquantel—Asthenia—Vinblastine—testicular cancer	0.000845	0.00472	CcSEcCtD
Praziquantel—Nervous system disorder—Ifosfamide—testicular cancer	0.000834	0.00466	CcSEcCtD
Praziquantel—Ill-defined disorder—Cisplatin—testicular cancer	0.000833	0.00466	CcSEcCtD
Praziquantel—Skin disorder—Ifosfamide—testicular cancer	0.000826	0.00462	CcSEcCtD
Praziquantel—Feeling abnormal—Bleomycin—testicular cancer	0.00082	0.00458	CcSEcCtD
Praziquantel—Vomiting—Chlorambucil—testicular cancer	0.000817	0.00457	CcSEcCtD
Praziquantel—Anorexia—Ifosfamide—testicular cancer	0.00081	0.00453	CcSEcCtD
Praziquantel—Malaise—Cisplatin—testicular cancer	0.00081	0.00453	CcSEcCtD
Praziquantel—Decreased appetite—Dactinomycin—testicular cancer	0.000806	0.00451	CcSEcCtD
Praziquantel—Diarrhoea—Vinblastine—testicular cancer	0.000806	0.00451	CcSEcCtD
Praziquantel—Fatigue—Dactinomycin—testicular cancer	0.0008	0.00447	CcSEcCtD
Praziquantel—Urticaria—Bleomycin—testicular cancer	0.00079	0.00442	CcSEcCtD
Praziquantel—Body temperature increased—Bleomycin—testicular cancer	0.000786	0.0044	CcSEcCtD
Praziquantel—Dizziness—Vinblastine—testicular cancer	0.000779	0.00435	CcSEcCtD
Praziquantel—Convulsion—Cisplatin—testicular cancer	0.000778	0.00435	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000775	0.00433	CcSEcCtD
Praziquantel—Myalgia—Cisplatin—testicular cancer	0.000765	0.00427	CcSEcCtD
Praziquantel—Feeling abnormal—Dactinomycin—testicular cancer	0.000764	0.00427	CcSEcCtD
Praziquantel—Nausea—Chlorambucil—testicular cancer	0.000763	0.00427	CcSEcCtD
Praziquantel—Ill-defined disorder—Etoposide—testicular cancer	0.000763	0.00427	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000759	0.00425	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000759	0.00424	CcSEcCtD
Praziquantel—Somnolence—Ifosfamide—testicular cancer	0.000756	0.00423	CcSEcCtD
Praziquantel—Discomfort—Cisplatin—testicular cancer	0.000755	0.00422	CcSEcCtD
Praziquantel—Vomiting—Vinblastine—testicular cancer	0.000749	0.00419	CcSEcCtD
Praziquantel—Malaise—Etoposide—testicular cancer	0.000742	0.00415	CcSEcCtD
Praziquantel—Vertigo—Etoposide—testicular cancer	0.000739	0.00413	CcSEcCtD
Praziquantel—Decreased appetite—Ifosfamide—testicular cancer	0.000739	0.00413	CcSEcCtD
Praziquantel—Headache—Vinblastine—testicular cancer	0.000738	0.00413	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000734	0.0041	CcSEcCtD
Praziquantel—Abdominal pain—Dactinomycin—testicular cancer	0.000733	0.0041	CcSEcCtD
Praziquantel—Body temperature increased—Dactinomycin—testicular cancer	0.000733	0.0041	CcSEcCtD
Praziquantel—Fatigue—Ifosfamide—testicular cancer	0.000733	0.0041	CcSEcCtD
Praziquantel—Hypersensitivity—Bleomycin—testicular cancer	0.000733	0.0041	CcSEcCtD
Praziquantel—Nervous system disorder—Cisplatin—testicular cancer	0.000719	0.00402	CcSEcCtD
Praziquantel—Asthenia—Bleomycin—testicular cancer	0.000714	0.00399	CcSEcCtD
Praziquantel—Convulsion—Etoposide—testicular cancer	0.000713	0.00399	CcSEcCtD
Praziquantel—Skin disorder—Cisplatin—testicular cancer	0.000712	0.00398	CcSEcCtD
Praziquantel—Pruritus—Bleomycin—testicular cancer	0.000704	0.00394	CcSEcCtD
Praziquantel—Feeling abnormal—Ifosfamide—testicular cancer	0.000701	0.00392	CcSEcCtD
Praziquantel—Eosinophilia—Methotrexate—testicular cancer	0.0007	0.00392	CcSEcCtD
Praziquantel—Nausea—Vinblastine—testicular cancer	0.0007	0.00391	CcSEcCtD
Praziquantel—Anorexia—Cisplatin—testicular cancer	0.000699	0.00391	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000696	0.00389	CcSEcCtD
Praziquantel—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000695	0.00389	CcSEcCtD
Praziquantel—Discomfort—Etoposide—testicular cancer	0.000692	0.00387	CcSEcCtD
Praziquantel—Hypersensitivity—Dactinomycin—testicular cancer	0.000683	0.00382	CcSEcCtD
Praziquantel—Abdominal discomfort—Methotrexate—testicular cancer	0.000678	0.00379	CcSEcCtD
Praziquantel—Urticaria—Ifosfamide—testicular cancer	0.000675	0.00378	CcSEcCtD
Praziquantel—Abdominal pain—Ifosfamide—testicular cancer	0.000672	0.00376	CcSEcCtD
Praziquantel—Body temperature increased—Ifosfamide—testicular cancer	0.000672	0.00376	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000668	0.00373	CcSEcCtD
Praziquantel—Asthenia—Dactinomycin—testicular cancer	0.000666	0.00372	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—testicular cancer	0.000655	0.00366	CcSEcCtD
Praziquantel—Skin disorder—Etoposide—testicular cancer	0.000652	0.00365	CcSEcCtD
Praziquantel—Anorexia—Etoposide—testicular cancer	0.00064	0.00358	CcSEcCtD
Praziquantel—Decreased appetite—Cisplatin—testicular cancer	0.000637	0.00356	CcSEcCtD
Praziquantel—Diarrhoea—Dactinomycin—testicular cancer	0.000635	0.00355	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000633	0.00354	CcSEcCtD
Praziquantel—Vomiting—Bleomycin—testicular cancer	0.000632	0.00354	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—testicular cancer	0.000631	0.00353	CcSEcCtD
Praziquantel—Rash—Bleomycin—testicular cancer	0.000627	0.00351	CcSEcCtD
Praziquantel—Dermatitis—Bleomycin—testicular cancer	0.000627	0.0035	CcSEcCtD
Praziquantel—Hypersensitivity—Ifosfamide—testicular cancer	0.000626	0.0035	CcSEcCtD
Praziquantel—Asthenia—Ifosfamide—testicular cancer	0.00061	0.00341	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—testicular cancer	0.000606	0.00339	CcSEcCtD
Praziquantel—Feeling abnormal—Cisplatin—testicular cancer	0.000604	0.00338	CcSEcCtD
Praziquantel—Pruritus—Ifosfamide—testicular cancer	0.000601	0.00336	CcSEcCtD
Praziquantel—Somnolence—Etoposide—testicular cancer	0.000597	0.00334	CcSEcCtD
Praziquantel—Nausea—Bleomycin—testicular cancer	0.000591	0.0033	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—testicular cancer	0.00059	0.0033	CcSEcCtD
Praziquantel—Vomiting—Dactinomycin—testicular cancer	0.00059	0.0033	CcSEcCtD
Praziquantel—Rash—Dactinomycin—testicular cancer	0.000585	0.00327	CcSEcCtD
Praziquantel—Decreased appetite—Etoposide—testicular cancer	0.000584	0.00326	CcSEcCtD
Praziquantel—Diarrhoea—Ifosfamide—testicular cancer	0.000582	0.00325	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Etoposide—testicular cancer	0.00058	0.00324	CcSEcCtD
Praziquantel—Body temperature increased—Cisplatin—testicular cancer	0.000579	0.00324	CcSEcCtD
Praziquantel—Fatigue—Etoposide—testicular cancer	0.000579	0.00324	CcSEcCtD
Praziquantel—Dizziness—Ifosfamide—testicular cancer	0.000562	0.00314	CcSEcCtD
Praziquantel—Feeling abnormal—Etoposide—testicular cancer	0.000553	0.00309	CcSEcCtD
Praziquantel—Nausea—Dactinomycin—testicular cancer	0.000551	0.00308	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—testicular cancer	0.000549	0.00307	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—testicular cancer	0.000546	0.00305	CcSEcCtD
Praziquantel—Vomiting—Ifosfamide—testicular cancer	0.000541	0.00302	CcSEcCtD
Praziquantel—Hypersensitivity—Cisplatin—testicular cancer	0.00054	0.00302	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—testicular cancer	0.000539	0.00302	CcSEcCtD
Praziquantel—Rash—Ifosfamide—testicular cancer	0.000536	0.003	CcSEcCtD
Praziquantel—Dermatitis—Ifosfamide—testicular cancer	0.000536	0.00299	CcSEcCtD
Praziquantel—Urticaria—Etoposide—testicular cancer	0.000533	0.00298	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—testicular cancer	0.000531	0.00297	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—testicular cancer	0.000531	0.00297	CcSEcCtD
Praziquantel—Asthenia—Cisplatin—testicular cancer	0.000526	0.00294	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—testicular cancer	0.000525	0.00294	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—testicular cancer	0.000511	0.00286	CcSEcCtD
Praziquantel—Nausea—Ifosfamide—testicular cancer	0.000505	0.00282	CcSEcCtD
Praziquantel—Diarrhoea—Cisplatin—testicular cancer	0.000501	0.0028	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—testicular cancer	0.000499	0.00279	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—testicular cancer	0.000495	0.00277	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—testicular cancer	0.000492	0.00275	CcSEcCtD
Praziquantel—Asthenia—Etoposide—testicular cancer	0.000482	0.00269	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—testicular cancer	0.000478	0.00268	CcSEcCtD
Praziquantel—Pruritus—Etoposide—testicular cancer	0.000475	0.00266	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—testicular cancer	0.000473	0.00265	CcSEcCtD
Praziquantel—Vomiting—Cisplatin—testicular cancer	0.000466	0.00261	CcSEcCtD
Praziquantel—Rash—Cisplatin—testicular cancer	0.000462	0.00258	CcSEcCtD
Praziquantel—Dermatitis—Cisplatin—testicular cancer	0.000462	0.00258	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—testicular cancer	0.000459	0.00257	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—testicular cancer	0.000457	0.00256	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—testicular cancer	0.000455	0.00254	CcSEcCtD
Praziquantel—Malaise—Methotrexate—testicular cancer	0.000444	0.00248	CcSEcCtD
Praziquantel—Dizziness—Etoposide—testicular cancer	0.000444	0.00248	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—testicular cancer	0.000443	0.00248	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—testicular cancer	0.000443	0.00248	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—testicular cancer	0.000438	0.00245	CcSEcCtD
Praziquantel—Nausea—Cisplatin—testicular cancer	0.000435	0.00243	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—testicular cancer	0.000428	0.00239	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—testicular cancer	0.000427	0.00239	CcSEcCtD
Praziquantel—Vomiting—Etoposide—testicular cancer	0.000427	0.00239	CcSEcCtD
Praziquantel—Rash—Etoposide—testicular cancer	0.000423	0.00237	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—testicular cancer	0.000423	0.00237	CcSEcCtD
Praziquantel—Headache—Etoposide—testicular cancer	0.000421	0.00235	CcSEcCtD
Praziquantel—Myalgia—Methotrexate—testicular cancer	0.00042	0.00235	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000417	0.00233	CcSEcCtD
Praziquantel—Malaise—Epirubicin—testicular cancer	0.000416	0.00233	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—testicular cancer	0.000415	0.00232	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—testicular cancer	0.000414	0.00232	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—testicular cancer	0.0004	0.00223	CcSEcCtD
Praziquantel—Nausea—Etoposide—testicular cancer	0.000399	0.00223	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—testicular cancer	0.000396	0.00221	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—testicular cancer	0.000394	0.00221	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—testicular cancer	0.000393	0.0022	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—testicular cancer	0.000391	0.00218	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00039	0.00218	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—testicular cancer	0.000388	0.00217	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—testicular cancer	0.000385	0.00215	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—testicular cancer	0.000383	0.00214	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—testicular cancer	0.000383	0.00214	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—testicular cancer	0.00037	0.00207	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—testicular cancer	0.000369	0.00206	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000366	0.00205	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—testicular cancer	0.000366	0.00204	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—testicular cancer	0.000363	0.00203	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000361	0.00202	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—testicular cancer	0.000359	0.00201	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—testicular cancer	0.000359	0.00201	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—testicular cancer	0.000358	0.002	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—testicular cancer	0.00035	0.00195	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000347	0.00194	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—testicular cancer	0.000347	0.00194	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000343	0.00192	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—testicular cancer	0.000342	0.00191	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—testicular cancer	0.000338	0.00189	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—testicular cancer	0.000335	0.00187	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—testicular cancer	0.000332	0.00186	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—testicular cancer	0.000331	0.00185	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—testicular cancer	0.000329	0.00184	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—testicular cancer	0.000327	0.00183	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000325	0.00182	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—testicular cancer	0.000324	0.00181	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—testicular cancer	0.000319	0.00179	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—testicular cancer	0.000318	0.00178	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—testicular cancer	0.000318	0.00178	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000317	0.00177	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—testicular cancer	0.00031	0.00173	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—testicular cancer	0.00031	0.00173	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—testicular cancer	0.000308	0.00172	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—testicular cancer	0.000303	0.00169	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000301	0.00168	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—testicular cancer	0.0003	0.00168	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—testicular cancer	0.000299	0.00167	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—testicular cancer	0.000298	0.00166	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—testicular cancer	0.000298	0.00166	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—testicular cancer	0.000296	0.00166	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—testicular cancer	0.000289	0.00161	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—testicular cancer	0.000287	0.0016	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000285	0.00159	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—testicular cancer	0.000285	0.00159	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—testicular cancer	0.000277	0.00155	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—testicular cancer	0.000277	0.00155	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—testicular cancer	0.000275	0.00154	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—testicular cancer	0.000275	0.00154	CcSEcCtD
Praziquantel—Diarrhoea—Methotrexate—testicular cancer	0.000275	0.00154	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—testicular cancer	0.00027	0.00151	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—testicular cancer	0.000266	0.00149	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—testicular cancer	0.000266	0.00149	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—testicular cancer	0.000258	0.00144	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—testicular cancer	0.000257	0.00143	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—testicular cancer	0.000256	0.00143	CcSEcCtD
Praziquantel—Rash—Methotrexate—testicular cancer	0.000254	0.00142	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—testicular cancer	0.000253	0.00142	CcSEcCtD
Praziquantel—Headache—Methotrexate—testicular cancer	0.000252	0.00141	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—testicular cancer	0.00025	0.0014	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—testicular cancer	0.000249	0.00139	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—testicular cancer	0.000246	0.00138	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—testicular cancer	0.000239	0.00134	CcSEcCtD
Praziquantel—Nausea—Methotrexate—testicular cancer	0.000239	0.00134	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—testicular cancer	0.000238	0.00133	CcSEcCtD
Praziquantel—Rash—Epirubicin—testicular cancer	0.000237	0.00133	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—testicular cancer	0.000237	0.00133	CcSEcCtD
Praziquantel—Headache—Epirubicin—testicular cancer	0.000236	0.00132	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—testicular cancer	0.00023	0.00129	CcSEcCtD
Praziquantel—Nausea—Epirubicin—testicular cancer	0.000224	0.00125	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—testicular cancer	0.000221	0.00124	CcSEcCtD
Praziquantel—Rash—Doxorubicin—testicular cancer	0.00022	0.00123	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—testicular cancer	0.000219	0.00123	CcSEcCtD
Praziquantel—Headache—Doxorubicin—testicular cancer	0.000218	0.00122	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—testicular cancer	0.000207	0.00116	CcSEcCtD
